221 
(I) to make a matching contribution of not more than 
50 percent of the total cost of the proposed project for 
which the grant is awarded; and 
(II) to repay to the Secretary the amount of the grant 
(or a portion thereof), interest on the amount at an ap-
propriate rate, and charges for administration of the 
grant the Secretary determines appropriate. 
(ii) LIMIT ON REPAYMENT.—The Secretary may not re-
quire that repayment under clause (i)(II) be more than 150 
percent of the amount of the grant, adjusted for inflation on 
the basis of the Consumer Price Index. 
(2) FOREIGN PARTNERS.—Partners may include Israel, the United 
Kingdom, Canada, Australia, Singapore, and other allies in the global 
war on terrorism as determined to be appropriate by the Secretary and 
the Secretary of State. 
(3) LOANS OF EQUIPMENT.—The Director may make or accept loans 
of equipment for research and development and comparative testing 
purposes. 
(d) FOREIGN REIMBURSEMENTS.—If the Science and Technology Home-
land Security International Cooperative Programs Office participates in an 
international cooperative activity with a foreign partner on a cost-sharing 
basis, reimbursements or contributions received from that foreign partner 
to meet its share of the project may be credited to appropriate current ap-
propriations accounts of the Directorate of Science and Technology. 
(e) REPORT TO CONGRESS ON INTERNATIONAL COOPERATIVE ACTIVI-
TIES.—The Secretary, acting through the Under Secretary for Science and 
Technology and the Director, shall submit to Congress every five years a 
report containing— 
(1) a brief description of each grant, cooperative agreement, or con-
tract made or entered into under subsection (b)(3)(C), including the 
participants, goals, and amount and sources of funding; 
(2) a list of international cooperative activities underway, including 
the participants, goals, expected duration, and amount and sources of 
funding, including resources provided to support the activities in lieu 
of direct funding; 
(3) for international cooperative activities identified in the previous 
reporting period, a status update on the progress of such activities, in-
cluding whether goals were realized, explaining any lessons learned, and 
evaluating overall success; and 
(4) a discussion of obstacles encountered in the course of forming, 
executing, or implementing agreements for international cooperative ac-
VerDate Sep 11 2014 
18:05 Jun 12, 2018
Jkt 079200
PO 00000
Frm 00221
Fmt 6652
Sfmt 6221
E:\BILLS\H6063.IH
H6063
pamtmann on DSKBFK8HB2PROD with BILLS
222 
tivities, including administrative, legal, or diplomatic challenges or re-
source constraints. 
(f) ANIMAL AND ZOONOTIC DISEASES.—As part of the international co-
operative activities authorized in this section, the Under Secretary, in co-
ordination with the Chief Medical Officer, the Department of State, and ap-
propriate officials of the Department of Agriculture, the Department of De-
fense, and the Department of Health and Human Services, may enter into 
cooperative activities with foreign countries, including African nations, to 
strengthen American preparedness against foreign animal and zoonotic dis-
eases overseas that could harm the Nation’s agricultural and public health 
sectors if they were to reach the United States. 
(g) CYBERSECURITY.—As part of the international cooperative activities 
authorized in this section, the Under Secretary, in coordination with the De-
partment of State and appropriate Federal officials, may enter into coopera-
tive research activities with Israel to strengthen preparedness against cyber 
threats and enhance capabilities in cybersecurity. 
(h) CONSTRUCTION; AUTHORITIES
OF
THE SECRETARY
OF STATE.— 
Nothing in this section shall be construed to alter or affect the following 
provisions of law: 
(1) Section 112b(c) of title 1. 
(2) Section 622(c) of the Foreign Assistance Act of 1961 (22 U.S.C. 
2382(c)). 
(3) Section 1(e)(2) of the State Department Basic Authorities Act 
of 1956 (22 U.S.C. 2651a(e)(2)). 
(4) Title V of the Foreign Relations Authorization Act, Fiscal Year 
1979 (22 U.S.C. 2656a et seq.). 
(5) Sections 2 and 27 of the Arms Export Control Act (22 U.S.C. 
2752, 2767). 
(i) AUTHORIZATION OF APPROPRIATIONS.—There are authorized to be 
appropriated to carry out this section such sums as are necessary. 
§ 10717. National biodefense strategy and implementation 
plan 
(a) DEFINITION OF APPROPRIATE CONGRESSIONAL COMMITTEE.—In this 
section, the term ‘‘appropriate congressional committee’’ means the fol-
lowing: 
(1) The congressional defense committees. 
(2) The Committee on Energy and Commerce of the House of Rep-
resentatives and the Committee on Health, Education, Labor, and Pen-
sions of the Senate. 
VerDate Sep 11 2014 
18:05 Jun 12, 2018
Jkt 079200
PO 00000
Frm 00222
Fmt 6652
Sfmt 6221
E:\BILLS\H6063.IH
H6063
pamtmann on DSKBFK8HB2PROD with BILLS
223 
(3) The Committee on Homeland Security of the House of Rep-
resentatives and the Committee on Homeland Security and Govern-
mental Affairs of the Senate. 
(4) The Committee on Agriculture of the House of Representatives 
and the Committee on Agriculture, Nutrition, and Forestry of the Sen-
ate. 
(b) STRATEGY AND IMPLEMENTATION PLAN.—The Secretary, the Secre-
taries of Defense, Health and Human Services, and Agriculture jointly shall 
develop a national biodefense strategy and associated implementation plan, 
which shall include a review and assessment of biodefense policies, practices, 
programs, and initiatives. The Secretaries shall review and, as appropriate, 
revise the strategy biennially. 
(c) ELEMENTS OF STRATEGY AND PLAN.—The strategy and associated 
implementation plan required under subsection (b) shall include each of the 
following: 
(1) An inventory and assessment of all existing strategies, plans, 
policies, laws, and interagency agreements relating to biodefense, in-
cluding prevention, deterrence, preparedness, detection, response, attri-
bution, recovery, and mitigation. 
(2) A description of the biological threats, including biological war-
fare, bioterrorism, naturally occurring infectious diseases, and acci-
dental exposures. 
(3) A description of the current program, efforts, or activities of the 
United States Government with respect to preventing the acquisition, 
proliferation, and use of a biological weapon, preventing an accidental 
or naturally occurring biological outbreak, and mitigating the effects of 
a biological epidemic. 
(4) A description of the roles and responsibilities of the executive 
agencies, including internal and external coordination procedures, in 
identifying and sharing information relating to, warning of, and pro-
tecting against, acts of terrorism using biological agents and weapons 
and accidental or naturally occurring biological outbreaks. 
(5) An articulation of related or required interagency capabilities and 
whole-of-Government activities required to support the national bio-
defense strategy. 
(6) Recommendations for strengthening and improving the current 
biodefense capabilities, authorities, and command structure of the 
United States Government. 
(7) Recommendations for improving and formalizing interagency co-
ordination and support mechanisms with respect to providing a robust 
national biodefense. 
VerDate Sep 11 2014 
18:05 Jun 12, 2018
Jkt 079200
PO 00000
Frm 00223
Fmt 6652
Sfmt 6221
E:\BILLS\H6063.IH
H6063
pamtmann on DSKBFK8HB2PROD with BILLS
224 
(8) Any other matters the Secretary and the Secretaries of Defense, 
Health and Human Services, and Agriculture determine necessary. 
(d) SUBMITTAL TO CONGRESS.—Not later than 275 days after December 
23, 2016, the Secretary and the Secretaries of Defense, Health and Human 
Services, and Agriculture shall submit to the appropriate congressional com-
mittees the strategy and associated implementation plan required by sub-
section (b). The strategy and implementation plan shall be submitted in un-
classified form but may include a classified index. 
(e) BRIEFINGS.—Not later than March 1, 2018, and 2019, the Secretary 
and the Secretaries of Defense, Health and Human Services, and Agri-
culture shall provide to the Committees on Armed Services, Energy and 
Commerce, Homeland Security, and Agriculture of the House of Represent-
atives a joint briefing on the strategy developed under subsection (b) and 
the status of the implementation of the strategy. 
(f) COMPTROLLER GENERAL REVIEW.—Not later than 180 days after the 
date of the submittal of the strategy and implementation plan under sub-
section (d), the Comptroller General shall conduct a review of the strategy 
and implementation plan to analyze gaps and resources mapped against the 
requirements of the national biodefense strategy and existing United States 
biodefense policy documents. 
§ 10718. Transparency in research and development 
(a) DEFINITIONS.—In this section: 
(1) ALL APPROPRIATE DETAILS.—The term ‘‘all appropriate details’’ 
means, with respect to a research and development project— 
(A) the name of the project, including classified and unclassified 
names if applicable; 
(B) the name of the component of the Department carrying out 
the project; 
(C) an abstract or summary of the project; 
(D) funding levels for the project; 
(E) project duration or timeline; 
(F) the name of each contractor, grantee, or cooperative agree-
ment partner involved in the project; 
(G) expected objectives and milestones for the project; and 
(H) to the maximum extent practicable, relevant literature and 
patents that are associated with the project. 
(2) CLASSIFIED.—The term ‘‘classified’’ means anything con-
taining— 
(A) classified national security information as defined in section 
6.1 of Executive Order 13526 (50 U.S.C. 3161 note) or any suc-
cessor order; 
VerDate Sep 11 2014 
18:05 Jun 12, 2018
Jkt 079200
PO 00000
Frm 00224
Fmt 6652
Sfmt 6221
E:\BILLS\H6063.IH
H6063
pamtmann on DSKBFK8HB2PROD with BILLS